Invention Grant
US09049849B2 Screening methods for compounds useful for treating pancreatic dysfunction
有权
用于治疗胰腺功能障碍的化合物的筛选方法
- Patent Title: Screening methods for compounds useful for treating pancreatic dysfunction
- Patent Title (中): 用于治疗胰腺功能障碍的化合物的筛选方法
-
Application No.: US13031095Application Date: 2011-02-18
-
Publication No.: US09049849B2Publication Date: 2015-06-09
- Inventor: Cord Dohrmann , Matthias Austen
- Applicant: Cord Dohrmann , Matthias Austen
- Applicant Address: DE Hamburg
- Assignee: EVOTEC INTERNATIONAL GMBH
- Current Assignee: EVOTEC INTERNATIONAL GMBH
- Current Assignee Address: DE Hamburg
- Agency: Ropes & Gray LLP
- Priority: EP02020829 20010917; EP02011963 20020529
- Main IPC: C40B30/04
- IPC: C40B30/04 ; C40B30/06 ; A61K38/17 ; A61K35/39 ; A01K67/027 ; C07K14/47
Abstract:
The present invention discloses polynucleotides which identify and encode DP119, DP444, DP810, DP685, WE474, DP160, RA977, or RA770 as well as novel functions for these proteins of the inventions. The invention provides for compositions for disorders associated with the expression of the proteins of the invention, such as for the treatment, alleviation and/or prevention of pancreatic dysfunction (for example diabetes, hyperglycemia, and impaired glucose tolerance), and related disorders, and other disease and disorders.
Public/Granted literature
- US20110277045A1 METHODS FOR INCREASING BETA CELL MASS COMPRISING ADMINISTERING A RA770 POLYPEPTIDE Public/Granted day:2011-11-10
Information query
